Analytic Investors’s PDL BioPharma, Inc. PDLI Stock Holding History

Analytic Investors’s Portfolio PDLI Stock Details PDLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	$1.17M	Buy	+348,837	New	+$1.11M	0.01%	350
2015 Q3	–	Sell	-147,237	Closed	-$947K	–	686
2015 Q2	$947K	Buy	+147,237	New	+$986K	0.01%	384
2014 Q4	–	Sell	-72,437	Closed	-$541K	–	678
2014 Q3	$541K	Buy	+72,437	New	+$673K	0.01%	450
2014 Q2	–	Sell	-78,850	Closed	-$655K	–	670
2014 Q1	$655K	Sell	78,850 -445,971	-85%	-$3.82M	0.01%	413
2013 Q4	$4.43M	Buy	524,821 +45,613	+10%	+$384K	0.07%	181
2013 Q3	$3.82M	Sell	479,208 -119,750	-20%	-$963K	0.06%	196
2013 Q2	$4.62M	Buy	+598,958	New	+$4.67M	0.08%	207

Other funds holding PDLI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Analytic Investors's PDLI Position: Q3 2016 in Review

Analytic Investors opened a new position in PDL BioPharma, Inc. (PDLI) in Q3 2016: 348,837 shares worth $1.17M. The stake represents 0.01% of the portfolio and ranks #350 among its holdings. This is a return to the name: Analytic Investors previously reported a position in PDLI as recently as Q2 2015.

Analytic Investors first reported a position in PDLI in Q2 2013 and has held it in 7 quarters since. The position peaked at $4.62M in Q2 2013. 198 funds tracked by Wall St. Rank hold PDLI as of Q3 2016.

Analytic Investors held 348,837 shares of PDL BioPharma, Inc. worth $1.17M as of Q3 2016.
PDL BioPharma, Inc. was a new Analytic Investors position in Q3 2016.
PDL BioPharma, Inc. made up 0.01% of Analytic Investors's portfolio in Q3 2016, its #350 holding.
Analytic Investors first reported a position in PDL BioPharma, Inc. in Q2 2013 and has held it in 7 quarters since.
Analytic Investors's PDL BioPharma, Inc. position peaked at $4.62M in Q2 2013.
198 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q3 2016.

Based on Analytic Investors's 13F filing for Q3 2016, filed 14 Nov 2016.